Commerce Bank Sells 6,220 Shares of CVS Health Co. (NYSE:CVS)

Commerce Bank lessened its position in CVS Health Co. (NYSE:CVS) by 7.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 72,342 shares of the pharmacy operator’s stock after selling 6,220 shares during the quarter. Commerce Bank’s holdings in CVS Health were worth $5,712,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of the company. SOA Wealth Advisors LLC. increased its holdings in shares of CVS Health by 4.9% during the 4th quarter. SOA Wealth Advisors LLC. now owns 2,859 shares of the pharmacy operator’s stock worth $226,000 after purchasing an additional 133 shares during the period. Apella Capital LLC increased its holdings in shares of CVS Health by 4.2% during the 4th quarter. Apella Capital LLC now owns 3,378 shares of the pharmacy operator’s stock worth $272,000 after purchasing an additional 136 shares during the period. Prairie Sky Financial Group LLC increased its holdings in shares of CVS Health by 4.1% during the 4th quarter. Prairie Sky Financial Group LLC now owns 3,612 shares of the pharmacy operator’s stock worth $285,000 after purchasing an additional 141 shares during the period. WealthShield Partners LLC increased its holdings in shares of CVS Health by 3.2% during the 4th quarter. WealthShield Partners LLC now owns 4,498 shares of the pharmacy operator’s stock worth $355,000 after purchasing an additional 141 shares during the period. Finally, Sugarloaf Wealth Management LLC increased its holdings in shares of CVS Health by 9.5% during the 4th quarter. Sugarloaf Wealth Management LLC now owns 1,639 shares of the pharmacy operator’s stock worth $129,000 after purchasing an additional 142 shares during the period. Institutional investors own 80.66% of the company’s stock.

Insider Activity at CVS Health

In other news, Director Edward J. Ludwig bought 1,000 shares of the stock in a transaction on Thursday, May 2nd. The stock was purchased at an average price of $53.88 per share, with a total value of $53,880.00. Following the completion of the purchase, the director now owns 21,630 shares of the company’s stock, valued at $1,165,424.40. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. 0.24% of the stock is currently owned by company insiders.

CVS Health Trading Down 0.2 %

Shares of NYSE CVS opened at $55.54 on Friday. The company’s 50 day simple moving average is $67.13 and its 200 day simple moving average is $71.92. CVS Health Co. has a fifty-two week low of $53.70 and a fifty-two week high of $83.25. The firm has a market capitalization of $69.72 billion, a P/E ratio of 9.76, a P/E/G ratio of 0.53 and a beta of 0.56. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.81 and a quick ratio of 0.61.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share for the quarter, missing the consensus estimate of $1.69 by ($0.38). CVS Health had a net margin of 2.03% and a return on equity of 13.53%. The business had revenue of $88.44 billion during the quarter, compared to analyst estimates of $89.33 billion. During the same quarter in the prior year, the company earned $2.20 earnings per share. The company’s quarterly revenue was up 3.7% on a year-over-year basis. On average, analysts predict that CVS Health Co. will post 7.02 EPS for the current year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 1st. Investors of record on Monday, April 22nd were issued a $0.665 dividend. The ex-dividend date of this dividend was Friday, April 19th. This represents a $2.66 annualized dividend and a yield of 4.79%. CVS Health’s dividend payout ratio is currently 46.75%.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on CVS shares. Leerink Partnrs cut shares of CVS Health from an “outperform” rating to a “market perform” rating in a research note on Wednesday, May 1st. StockNews.com cut shares of CVS Health from a “buy” rating to a “hold” rating in a research note on Thursday, February 15th. Cantor Fitzgerald cut shares of CVS Health from an “overweight” rating to a “neutral” rating and lowered their target price for the company from $87.00 to $58.00 in a research note on Wednesday, May 1st. TD Cowen cut shares of CVS Health from a “buy” rating to a “hold” rating and lowered their target price for the company from $99.00 to $59.00 in a research note on Tuesday, May 7th. Finally, Barclays lowered their target price on shares of CVS Health from $78.00 to $63.00 and set an “equal weight” rating on the stock in a research note on Thursday, May 2nd. Nine research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat, CVS Health presently has an average rating of “Moderate Buy” and a consensus target price of $76.75.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.